Over 15 million Americans have signed up for health insurance using the Affordable Care Act's federal marketplace, a 33% increase from the year before, preliminary government data shows.
On Dec. 15, the deadline for coverage that starts Jan. 1, a whopping 745,000 people ...
A large fraction of Americans nearing retirement age are worried they can't afford health insurance now, much less when they quit working to enjoy the good life, a new survey shows.
One in every four people between 50 and 64 are not confident they'll be able to affor...
The physical and mental health of poor people is less likely to be at risk in Southern U.S. states that expanded their Medicaid programs under Obamacare, a new study finds.
Researchers analyzed data from more than 15,500 low-income adults in 12 Southern states and fo...
Medical paperwork cost the United States $812 billion in 2017 and accounted for more than one-third of total spending for doctor visits, hospitals, long-term care and health insurance, according to a new study.
However, reducing medical paperwork expenses to the same...
Seniors on Medicare are going to take a hit to the pocketbook in 2020, with premiums and deductibles set to increase on coverage for medical services and prescription drugs.
The standard monthly premium for Medicare Part B will rise $9.10, to $144 a month, the U.S. C...
A solid minority of senior citizens still struggles to afford their prescription medications, a new government report shows.
About 5% of adults 65 and older don't take their medication as prescribed to cut costs, according to survey data from the U.S. Centers for...
While President Donald Trump's latest push to dismantle Obamacare is on hold for now, millions still stand to lose health insurance if it is ever repealed.
"Vote will be taken right after the Election when Republicans hold the Senate & win back the House," Trump ...
For people with the deadly skin cancer melanoma, one dose of the drug Keytruda before surgery might stop the cancer in its tracks, according to a groundbreaking new study.
Keytruda (pembrolizumab) is a PD-1 inhibitor, an immunotherapy drug that triggers the body's im...
Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS).
Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a...
Many middle-aged folks nearing retirement have serious concerns about their health insurance coverage, a new survey shows.
Nearly half of people aged 50 to 64 say they have little or no confidence they'll be able to afford health coverage once they retire, according ...